The prevalence of asthma, measured either as the frequency of hospital admissions or number of deaths attributed to asthma, has increased over the last 15 to 20 years. Rapid increases in disease prevalence are more likely to be attributable to environmental than genetic factors. Inferring from past associations between air pollution and asthma, it is feasible that changes in the ambient environment could contribute to this increase in morbidity and mortality. Scientific evaluation of the links between air pollution and the exacerbation of asthma is incomplete, however. Currently, criteria pollutants [SOX, NOW, 03, CO, Pb, particulate matter (PM10)] and other risk factors (exposure to environmental tobacco smoke, volatile organic compounds, etc.) are constantly being evaluated as to their possible contributions to this situation. Data from these studies suggest that increases in respiratory disease are associated with exposures to ambient concentrations of particulate and gaseous pollutants. Similarly, exposure to environmental tobacco smoke, also a mixture of particulate and gaseous air toxics, has been associated with an increase in asthma among children. In addition, current associations of adverse health effects with existing pollution measurements are often noted at concentrations below those that produce effects in controlled animal and human exposures to each pollutant alone. These findings imply that adverse responses are augmented when persons are exposed to irritant mixtures of particles and gases and that current measurements of air pollution are, in part, indirect in that the concentrations of criteria pollutants are acting as surrogates of our exposure to a complex mixture. Other irritant air pollutants, including certain urban air toxics, are associated with asthma in occupational settings and may interact with criteria pollutants in ambient air to exacerbate asthma. An evaluation of dose-response information for urban air toxics and biological feasibility as possible contributors to asthma is therefore needed. However, this evaluation is compounded by a lack of information on the concentrations of these compounds in the ambient air and their effects on asthma morbidity and mortality. Through an initial review of the current toxicological literature, we propose a tentative list of 30 compounds that could have the highest impact on asthma and respiratory health. These compounds were selected based on their ability to induce or exacerbate asthma in occupational and nonoccupational settings, their allergic potential and ability to react with biological macromolecules, and lastly, their ability to irritate the respiratory passages. We recommend better documentation of exposure to these compounds through routine air sampling and evaluation of total exposure and further evaluation of biological mechanisms through laboratory and epidemiological studies directed specifically at the role these substances play in the induction and exacerbation of asthma. -Environ Health Perspect 1 03(Suppl 6): 253-271 (1995) 
Introduction Urban Air Toxics
The Title III-Hazardous Air Pollutants portion of the 1990 Clean Air Act Amendment mandates the preparation of exposure standards for an initial list of 189 compounds within 6 years and a comprehensive strategy to control emissions from sources in urban areas within 5 years. The latter requires an identification of not less than 30 hazardous air pollutants that present the greatest threat to public health in the largest number of urban areas. Several health concerns are to be considered, with emphasis on carcinogenicity, mutagenicity, and teratogenicity. In the review that follows, we consider the possible relationship between these compounds and an additional disease, asthma. Asthma morbidity (emergency room visits, etc.) and mortality have steadily increased since the mid-I 970s, a situation that will require a better understanding of environmental risk factors.
Clean air is essential for life. Human commerce and recreation have led to the purification, development, and macroscale use of over 50,000 chemicals. Each can be considered toxic depending on the magnitude of exposure, the dose to target organ, and the biological response. Systematic evaluation and reevaluation of the toxicology of these chemicals is ongoing and may require many decades of effort to understand the relationships between environmental exposure and potential to cause or exacerbate human diseases. Faced with the immediate need to protect human health by providing recommendations for over 180 compounds (Table 1) , referred to here as urban air toxics (UATs), we attempt to rank this substantial list of compounds (and groups of compounds). Any prioritization should be based on the likelihood and extent of human exposure and the severity of the response. Unfortunately, adequate scientific details are lacking for Environmental Health Perspectives Air quality standards are designed to protect susceptible populations, and persons with asthma are clearly at increased risk from the adverse health effects of air pollution. Because asthma is a complex respiratory condition with varied definitions (1) (2) (3) , it is helpful to develop an operational definition of this disease. Asthma is defined here as a respiratory disease with three primary features. The first is airway inflammation (associated with eosinophilic infiltration and altered T-cell lymphocytic function). A second feature is altered epithelial function (associated with thickening of the basement membrane, mucin hypersecretion, loss or altered ciliary structure, and altered cytokine and other inflammatory mediator production). The third and most predominate feature is recurrent airflow obstruction (presented in dual phases as decreased forced expiratory volume, bronchospasm, or airway hyperreactivity). Although the frequency of asthma is greater among atopic individuals (4) , not all persons with asthma (e.g., more than half the adults with occupational asthma) (5) exhibit specific antigen-antibody responses. Instead, these individuals respond to many agents including dry air, hypo/hypertonic aerosols, acidic aerosols, and sulfur dioxide. Consequently, this condition is called nonspecific airway hyperreactivity, which many clinical investigators consider the hallmark of asthma (2, 6) .
Although asthma may persist for many years, the signs and symptoms are markedly erratic both in frequency and severity. In some ways, this intrinsic, sporadic nature contributes to the licentiousness of this disease. Severe, life-threatening asthmatic attacks can arise rapidly even after presentation of mild symptoms to which the victim is accustomed. Thus, patients and physicians may depend solely on selfadministered bronchodilators for therapy assuming relief is shortly in hand, only to be faced with a rapidly mounting array of irreversible changes (e.g. airway obstruction by mucus inspissation). Indeed, this lack of appreciation for this condition by patients and general practitioners has been cited as contributing to the recent increases in asthma mortality (7, 8) .
One factor that has been considered as having a possible role in the recent increases in asthma mortality is the use of bronchodilator therapy (9) (10) (11) . Without recognition of the inflammatory and epithelial components of this disease, therapies directed solely at preventions of bronchospasm can leave a persistent inflammatory condition unchecked. In addition, patients relieved of symptoms may be more likely to put themselves in harm's way by not avoiding environmental exposures that increase epithelial injury and may hasten acute attacks. In addition, bronchodilation will alter the deposition pattern of subsequently inhaled irritant particles increasing their penetration to distal, small diameter airways and lengthening clearance times.
In the past, controlled human exposures of persons with asthma indicate that these patients respond to bronchoconstrictive substances at lower concentrations than do healthy control subjects (12) . Of the current criteria pollutants, SO2 (13, 14) , NO2 (15) (16) (17) (18) , and acidic sulfates (19) (20) (21) (22) (23) can produce bronchoconstriction (or increase bronchial reactivity) at lower concentrations among asthmatic subjects. Clinical studies with ozone are more controversial (24) (25) (26) , although a recent study by Molfino (27) suggests that 03 exposures can increase bronchial reactivity to subsequent antigen challenges in persons with airway hypersensitivity. Results from these studies qualitatively indicate that specific pollutants affect persons with asthma to a greater extent than healthy subjects. However, clinical findings are quantitatively disparate from epidemiological findings in that in clinical studies, the lowest effective concentration that produces bronchoconstriction is often higher than that noted to produce adverse pulmonary effects when subjects are exposed in free-roving environments. Because asthma varies in its severity, a selection bias of subjects with milder forms of the disease could be responsible for the difference noted between clinical and epidemiological studies.
In several recent epidemiological studies, associations between air pollution and the prevalence of respiratory symptoms characteristic of asthma have been noted throughout the world (Table 2 ). When atopic and nonatopic patients were handled separately, the association with air pollution was unaffected (31, 33, 34) . This suggests that both asthma subpopulations are affected equally by air pollution. Besides increases in symptoms, air pollution has been associated with decreases in pulmonary function, e.g., depressed forced expiratory volume-1 second (FEVy) or peak expiratory flowrate (PEF) (35, 36) .
Emergency department visits and hospital admissions for asthma have also been consistently associated with the amount of exposure to air pollution (Table 3) . The implicated air pollution variable differs among studies, with the most frequent being particulate, sulfate, and sulfur dioxide. In contrast, earlier studies failed to find similar associations with SO2 and hospital admissions for asthma (47 (32, 41, 44, (48) (49) (50) . Local stationary sources are often associated with effects (31, 38, 45, (51) (52) (53) (54) (55) (56) (57) . This observation, along with the observation that a variety of pollutants are associated with the same responses (Tables 2,3 ), suggests that the specific compounds measured may serve as indicators of a wider array of air pollutants (including UATs). By focusing on selected epidemiological studies that have been conducted in the last 5 years, emphasis is placed on the current effects of air pollution. All the reported associations have been noted during a period when criteria pollutants are either decreasing or maintaining levels noted in previous years (50, 58) . Last, because some recent studies are cross-sectional over short periods, it is unlikely that any recent changes in diagnostic criteria for asthma could explain these associations (59) (60) (61) (62) . Together these studies indicate that air pollution is a complex mixture that can produce effects at current levels of exposure that are important to the etiology of asthma. (33) "Particulate < 10 pm. Emission inventories for UATs indicate that release into the air is the principal route through which these materials enter the environment (Figure 1 ).
In addition to direct entry from stationary sources by volatilization, specific compounds can enter the urban air by (63) . mechanical dispersion or condensation, processes that dominate the formation of the urban aerosol. Urban aerosols have been chemically characterized to a limited extent in the past (64) (65) (66) (67) (68) (69) (70) (71) . However, the past and current criteria pollutants, total suspended particulate (TSP), and particulate material < 10 pm (PMlo) overlap with specific UATs because particles in this size range and smaller are derived from anthropogenic sources, whereas larger particles (>10 pm) arise from natural sources (e.g., sea salt, soil, etc.). More details of the implication of the ambient levels of particulate matter to asthma are presented below.
A third source of atmospheric pollutants arises from secondary reactions in the atmosphere. Many reactive hydrocarbons (often with very short half-lives) can be formed and can accumulate in the atmosphere (72) (73) (74) (75) (76) . This is particularly important for urban photo-oxidant plumes most often associated with ozone formation. Because ozone formation is dependent upon reactive hydrocarbon species (e.g., aldehydes), the continuous measurement of ozone concentrations could be useful in estimating the ambient concentrations of these compounds. Once inhaled, ozone is likely to react with unsaturated fatty acid in the airway lining fluid or the cell membrane to form aldehydes, hydroxyhydroperoxides, and hydrogen peroxide (77, 78 activity in equivalent response occurred after 1.1 ppm t into the x 8 hr = 8.8 ppm x hr that is nearly 7 ample, we times less than what would be predicted by 1 of hyper-31 ppm x 2 hours = 62 ppm x hr). These posed to findings suggest that low-level exposure of ). In these prolonged duration may be of greater cone necessary sequence than would be predicted by acute e (ED200) exposure. This would explain why some exposures. clinical studies with exposures of short extended to duration (< 4 hr) do not uncover effects at than that levels that are associated with pulmonary timates of effects in epidemiological studies. ) 1.1 ppm Induction of irritant-induced asthma change in without a latency period has also been equivalent reported extensively in the medical literature by 2 hr of and has been termed reactive airways dysmaldehyde function syndrome (RADS) (85 (94), and ammonia (95, 96) . This condition differs from typical occupational asthma because it lacks a preceding latent period and can be -,-,-,-,-,, initiated by a single exposure. Persons with 100 this syndrome often experience subsequent responses to a wide range of agents (non-8-hrexposure specific airway hyperreactivity) and workers report that symptoms are equivalent either at home or at work (97-100). Because of a lack of exposure measurements during the initiating events, is it difficult to establish a threshold for this type of response; nonetheless, it is assumed that very high exposure levels are responsible for these cases.
Exposure Assessment and the Exacerbation ofAsthma 100 In addition to scientific uncertainties associated with the establishment of threshold of acrolein doses for chemicals that induce asthma, the I) on airway levels of occupational exposure necessary to (107) . bOdor thresholds are lowest value reported.
Environmental Health Perspectives Table 1 ).
being more frequent when levels exceed 1700 pg/mr.
To investigate whether these compounds influenced pulmonary functions among persons with asthma, controlled 1.5 hr exposures were performed at concentration of total VOC of 2.5 and 25 mg/mi3 (113) . At the end of the 25 Table 1 with Table 11 ). Each is a complex mixture of chemicals in both gas and particle phase. Because of these similarities, it is relevant to compare and contrast ETS and UATs in asthma.
ETS exposure has been assessed by measurement of a number of its constituents in air. Nicotine, respirable suspended particulate (RSP = PM < 2.5 prm), benz[a]pyrene, benzene, formaldehyde, toluene, carbon monoxide, 4-aminobiphenyl, and other chemicals have been used to assess ETS exposure. Of these, nicotine and RSP have the widest application, and these two variables correlate reasonably XRSP = 17.9 ± 10.8 nicotine; each in pg/mr) (138) . Either measure has been used as ETS exposure surrogates, and when measured together can accurately represent the frequency, duration, and magnitude of ETS exposure (136) .
Because nicotine is not suspected of inducing asthma and is not a UAT, and because RSP contains many compounds that affect asthma and are UATs, a preliminary evaluation of the magnitude of RSP exposure associated with increased asthma is worthwhile. The amount of RSP produced in the breathing zone of a child will vary with the number of smokers, proximity to the smokers, ventilation, and other variables. Nonetheless, average room RSP concentrations (obtained from 2 (138) (139) (140) .
Increases in the incidence and prevalence of asthma among children have been noted when mothers smoke 10 or more cigarettes per day (141, 142 Figure 3 suggest an association with an increase in symptoms with an increase in maternal smoking (143) . Again Several factors are uncertain in these comparisons, however. First, because maternal smoking has a greater effect than paternal smoking, it also may influence the development of asthma in utero by limiting lung development (145) (146) (147) . In addition, average concentrations of room air samples may underpredict the levels in a child's breathing zone because small children are often held by their mothers. This proximity could result in complex exposure patterns of intermittent high-level exposures of short duration. Conversely, older children spend less time at home or in a room with a parent who smokes. Exposure patterns to UATs also may be intermittent, with wide variances in concentration. Thus, it is important to obtain time-activity information to predict personal exposures by combining microenvironmental concentration information with duration of exposure obtained from time-activity analyses.
Second, the physical and chemical properties of ETS differ from those of the ambient mixture of gaseous and particulate UATs. Although several main irritants are contained in both, the levels of most are greater in ETS than in urban air. The particle size also may differ in that ETS is < 1.0 pm [sidestream smoke is typically 0.001-1.0 pm and mainstream smoke is 0.1-1.0 pm in diameter (148) Common asthmagens identifiable by this method include metals (chromium trioxide, chromates, nickel sulfate, and platinum compounds). Such an approach is particularly useful in diagnosis of occupational asthma and is aided by knowledge of the chemicals present in the workplace and the reversal of symptoms upon their removal from the workplace. Although much can be learned by this diagnostic strategy, it may be impractical to apply this approach to future evaluations of the toxicity of over 189 compounds.
Further, certain known occupational asthmagens act by an immunologic mechanism in some persons, but not in others. These compounds include polyisocyanates, acid anhydrides, and aldehydes. In these cases, the threshold concentration needed to produce bronchospasm is likely to below that necessary to induce nonimmunospecific irritation. Other substances (acting like sulfur dioxide and perhaps ozone) do not produce antigenic responses but can provoke bronchoconstriction in persons with asthma at concentrations that are lower than those that are bronchoconstrictive in healthy subjects. These chemicals may act as an irritant and have an ability to induce airway epithelial injury and inflammation, effects that can be barely perceptible at doses in the range occurring in the environment. Released from stationary sources, such UATs can mix with other toxic chemicals in the urban air and add to the irritant load presented to persons with asthma in the general population.
Many UATs have insufficient scientific data to evaluate their immunologic potential, however. Because of this situation, because it is difficult to limit the definition of asthma to antigenic responses, and because of difficulties in ascertaining whether each chemical by itself causes or Volume 103, Supplement 6, September 1995 (152) , the broader chemical to their effects in occupational settings. properties of UATs need to be considered.
Other UATs share a portion of these Properties that are important to this ques-properties, but it is unclear whether they tion include respirability, irritancy, and can induce persistent asthma. Adding to skin antigenicity. the difficulty of this situation are the Several compounds identified as UATs uncertainties created by the gaps in the litshare these properties and can clearly be erature regarding the human toxicity of classified as suspected human asthmagens. each compound. Nonetheless, to develop These compounds are listed in Table 13 . logical strategies to assess possible links These compounds have had documented between environmental exposure to these reports in the medical literature associating compounds and asthma, the limited human exposure with asthma (either as human experience must be considered. inducers or exacerbaters). This includes This second group of compounds (Table  polyisocyanates , aldehydes, anhydrides, 14) includes skin allergens (compounds and metals-compounds with wide accep-producing allergic contract dermatitis) (111, 113, 114) and epidemiologic studies (165) Tables 5 and 6 and the TLVs presented in Tables 17 and  18 indicates that odor thresholds are often above recommended exposure limits, suggesting that when odor is detected, significant exposure can occur.
Also presented in Tables 17 and 18 Tables 17 and 18 are the current reference exposure levels (RELs) developed for California (175 Table 17 .)
The number of persons living near emitting point sources is unknown but could be derived from census data and information on the location of point sources throughout the United States. Furthermore, the percentage of persons in these populations that have asthma can be estimated based on NHANES survey. It would be useful to estimate the extent of exposure to these identifiable asthmagens. Such data could be useful in assessments of health care costs (178) .
Last, the current epidemiological information on the possible associations between UATs and asthma is inadequate. Recent studies with criteria pollutants suggest that animal and clinical exposure data can underestimate respiratory health effects. One epidemiological study of formaldehyde suggests that children exposed in homes with concentrations of >150 pg/mi3 had a higher frequency of asthma and bronchitis than children with residential exposure <50 pig/mi3 (179) .
Decrements in PEF were also correlated with formaldehyde exposure. Clinical studies with formaldehyde, in contrast, require much higher concentrations to produce transient increases in airway resistance (171) . This suggests that persistent respiratory effects can result from indoor formaldehyde exposures and that environmental exposures produce effects not observed in clinical studies with short-term exposures. Confirmation through additional investigation of the effects of environmental aldehyde and other UAT exposure on persistent pulmonary function is thus warranted.
Conclusions
In summary, asthma is a serious illness with a high prevalence among the general population. Over the last 15 years, the incidence and severity of asthma have continued to increase. In the past, exposure to air pollution has been associated with an increase in respiratory symptoms and hospital admissions for asthma. The 
